Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy.

Hsu, Grace; Bernhardi, Ciera; Lawson, Justin; Duong, Vu H; Emadi, Ashkan; Niyongere, Sandrine; Duffy, Alison

Hsu, Grace; Bernhardi, Ciera; Lawson, Justin; Duong, Vu H; Emadi, Ashkan; Niyongere, Sandrine; Duffy, Alison.

Afiliación

Hsu G; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Bernhardi C; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Lawson J; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Duong VH; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Emadi A; School of Medicine, University of Maryland School, Baltimore, MD, USA.
Niyongere S; Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD, USA.
Duffy A; School of Medicine, University of Maryland School, Baltimore, MD, USA.

J Oncol Pharm Pract ; : 10781552231205824, 2023 Oct 10.

Article en En | MEDLINE | ID: mdl-37817569

Palabras clave

CINV; Chemotherapy-induced nausea and vomiting; leukemia; multiday chemotherapy; olanzapine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Oncol Pharm Pract Asunto de la revista: FARMACIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google